Myomo (NYSEAMERICAN:MYO) Director Thomas Kirk Acquires 25,000 Shares

Myomo, Inc. (NYSEAMERICAN:MYO) Director Thomas Kirk acquired 25,000 shares of the stock in a transaction dated Thursday, May 28th. The stock was acquired at an average cost of $0.99 per share, with a total value of $24,750.00. Following the completion of the transaction, the director owned 653,863 shares in the company, valued at approximately $647,324.37. This represents a 3.98% increase in their position. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.

Myomo Stock Performance

Shares of Myomo stock opened at $1.09 on Monday. Myomo, Inc. has a one year low of $0.61 and a one year high of $3.14. The firm has a market capitalization of $42.12 million, a price-to-earnings ratio of -3.03 and a beta of 1.47. The business has a 50-day simple moving average of $0.81 and a 200 day simple moving average of $0.85. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.73 and a quick ratio of 2.36.

Wall Street Analyst Weigh In

Separately, Craig Hallum reaffirmed a “buy” rating on shares of Myomo in a research report on Tuesday, March 10th. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Myomo currently has a consensus rating of “Buy” and an average price target of $7.67.

Institutional Trading of Myomo

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jefferies Financial Group Inc. bought a new stake in Myomo during the 4th quarter worth approximately $641,000. Bank of America Corp DE increased its holdings in Myomo by 93.6% during the 3rd quarter. Bank of America Corp DE now owns 30,412 shares of the company’s stock worth $27,000 after purchasing an additional 14,705 shares in the last quarter. Invesco Ltd. bought a new stake in Myomo during the 2nd quarter worth approximately $37,000. Prescott Group Capital Management L.L.C. bought a new stake in Myomo during the 4th quarter worth approximately $169,000. Finally, Rosalind Advisors Inc. increased its holdings in Myomo by 5.4% during the 3rd quarter. Rosalind Advisors Inc. now owns 3,790,788 shares of the company’s stock worth $3,381,000 after purchasing an additional 195,000 shares in the last quarter. 44.99% of the stock is owned by institutional investors.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.